PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 208 filers reported holding PTC THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $29,770 | -92.3% | 732 | -90.8% | 0.00% | -100.0% |
Q1 2023 | $387,375 | -89.4% | 7,997 | -89.0% | 0.00% | -90.9% |
Q3 2022 | $3,638,000 | +363700.0% | 72,477 | +329340.9% | 0.01% | – |
Q1 2021 | $1,000 | -100.0% | 22 | -100.0% | 0.00% | -100.0% |
Q4 2020 | $2,772,000 | +4940.0% | 45,419 | +3613.7% | 0.01% | – |
Q1 2020 | $55,000 | -99.7% | 1,223 | -99.7% | 0.00% | -100.0% |
Q4 2019 | $21,364,000 | +5322.3% | 444,803 | +3714.1% | 0.05% | +4700.0% |
Q3 2019 | $394,000 | -50.6% | 11,662 | -60.4% | 0.00% | -50.0% |
Q1 2018 | $797,000 | +4588.2% | 29,457 | +2831.0% | 0.00% | – |
Q4 2017 | $17,000 | -66.7% | 1,005 | -60.6% | 0.00% | – |
Q3 2017 | $51,000 | -32.0% | 2,551 | -37.6% | 0.00% | – |
Q2 2017 | $75,000 | +38.9% | 4,085 | -25.9% | 0.00% | – |
Q1 2017 | $54,000 | +390.9% | 5,511 | +466.4% | 0.00% | – |
Q4 2016 | $11,000 | +1000.0% | 973 | +3792.0% | 0.00% | – |
Q3 2016 | $1,000 | -99.2% | 25 | -99.9% | 0.00% | – |
Q2 2016 | $118,000 | – | 16,868 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Burrage Capital Management LLC | 160,372 | $7,594,000 | 6.15% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 408,000 | $19,319,000 | 5.11% |
RTW INVESTMENTS, LP | 5,293,966 | $250,669,000 | 3.91% |
GEORGE KAISER FAMILY FOUNDATION | 72,105 | $9,925,000 | 2.07% |
SECTORAL ASSET MANAGEMENT INC | 504,928 | $23,908,000 | 1.81% |
Redwood Investments, LLC | 385,014 | $18,230,000 | 1.60% |
ARMISTICE CAPITAL, LLC | 1,396,000 | $66,101,000 | 1.52% |
Integral Health Asset Management, LLC | 100,100 | $4,740,000 | 1.35% |
Sofinnova Investments, Inc. | 466,840 | $22,105,000 | 1.33% |
Chubb Ltd | 8,180 | $387,000 | 1.10% |